Safety and Efficacy of Trifluridine-Tipiracil Hydrochloride Oral Combination (TAS-102) in Patients with Unresectable Colorectal Cancer

Aim: To retrospectively examine efficacy and safety of oral combination of trifluridine and tipiracil hydrochloride (TAS-102) as the second-line therapeutic agent for unresectable colorectal cancer. Patient and Methods: Treatment outcomes of 17 patients who had received TAS-102 at our Institution fr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:In Vivo
Hauptverfasser: NARIHIRO, SATOSHI, SUWA, KATSUHITO, USHIGOME, TAKURO, OHTSU, MASAMICHI, RYU, SYUNJIN, SHIMOYAMA, YUYA, OKAMOTO, TOMOYOSHI, YANAGA, KATSUHIKO
Format: Artigo
Sprache:Inglês
Veröffentlicht: International Institute of Anticancer Research 2018
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6365739/
https://ncbi.nlm.nih.gov/pubmed/30348728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11426
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge